Related Experiment Videos
Augmentation strategies with serotonergic-noradrenergic combinations
1Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA.
The Journal of Clinical Psychiatry
|June 27, 1998
Summary
Combining antidepressants that target serotonin and norepinephrine may effectively treat severe or treatment-resistant depression. This review discusses combinations of selective serotonin reuptake inhibitors with tricyclics or bupropion.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Refractory and severe depression require effective treatment strategies.
- Dual-acting antidepressants offer potential therapeutic benefits.
Purpose of the Study:
- To review studies on antidepressant combinations.
- To discuss practical aspects of using these combinations.
Main Methods:
- Literature review of studies combining selective serotonin reuptake inhibitors (SSRIs) with noradrenergic tricyclics or bupropion.
Main Results:
- Combinations of SSRIs and noradrenergic agents may enhance antidepressant efficacy.
- Practical considerations for using these combinations are highlighted.
Conclusions:
- Antidepressant combinations targeting both serotonin and norepinephrine show promise for difficult-to-treat depression.
- Further research and clinical guidance are needed for optimal application.